The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.
about
Insulin and insulin resistance.Review article: the metabolic syndrome and non-alcoholic fatty liver diseaseAndrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacologyRegulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2Insulin resistance: regression and clusteringUtility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional studyInsulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats.Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome.Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes.Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health.Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders.Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis.Metabolic syndrome and cardiovascular risk.Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosisMicroarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications.Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors.Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia.Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial.Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes.Non-alcoholic fatty liver disease and psoriasis: So far, so near.Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial.Sleep disorder and cardiovascular risk factors among patients with type 2 diabetes mellitusCardiometabolic risk among African American women: a pilot study.Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndromeDemonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome.The role of cortisol in the pathogenesis of the metabolic syndromeCirculatory syndrome: an evolution of the metabolic syndrome concept!NOX4 pathway as a source of selective insulin resistance and responsivenessPlasma betatrophin levels in patients with liver cirrhosisShould nonalcoholic fatty liver disease be renamed?Characterisation of morbidity in a UK, hospital based, obesity clinic.Effect of vitamins a, C, and e supplementation in the treatment of metabolic syndrome in albino ratsMetabolic syndrome--cardiovascular disease risk and more.The metabolic syndrome: one step forward, two steps back.All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals.Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.Contribution of CB1 blockade to the management of high-risk abdominal obesity.
P2860
Q24532776-72B2BDA1-3517-4E74-8139-C003534031B8Q28192695-637132B8-B584-4BAF-9E86-D36350973002Q28261671-718E0F76-BD0E-4BE4-9909-4B9714099B91Q28272571-46B6D879-0D3D-4280-AF61-8F5DF7293F97Q28658941-9AD341E1-0A30-4F92-825A-28E0D49F6403Q33273785-842D8580-2B15-4297-B48A-B59669A453CAQ33556119-67E7546B-6BC1-4FE8-B5FA-45C19AADCA78Q33650508-0BAC38C3-AB1A-4F30-9431-604D2B543012Q33843310-BAEF4927-2E3B-4C15-A22D-74916AC23EB0Q34040213-864B9B98-3AC6-4992-8DB6-6FBC310CB162Q34098356-C85FB9AE-74B9-46C0-B3D8-4B16967734A3Q34107014-28CFC2CD-7402-4290-AADC-89CCFD8E1352Q34570641-A1BCD69D-1D29-4D2D-B804-22374E4C94F6Q34606875-3469B9ED-1141-416F-B936-0E5E2FC1A4DBQ34609585-9E8FD17C-CB83-49DF-BA76-68A283A9F3A4Q34974769-F918F9FA-D9A2-408A-82AE-77AB38E19C9CQ35006282-0A65C751-CDA3-4D81-928D-720AC566262AQ35006445-ECEE2573-4664-40FB-87DC-2E950DD4BAB5Q35025237-04455812-2EC4-4E85-9485-1615B8E3F864Q35205907-6EF2C8B9-D4CF-4068-9062-398A4F20445AQ35237307-AFF2C3B7-1223-4289-A14C-CF23A6D6B3CCQ35264479-2A885CE3-8BBE-453F-A484-8311004465E9Q35331587-B0707A3C-4E10-48FE-9361-E5BC303D3A37Q35485393-E259B9CA-53E4-4485-835C-D10EF0EB8D64Q35753018-A0E6D367-BD4A-43FF-9350-3E9B5F6C930DQ35858095-A24BF175-41D4-4EF4-9ACB-2C45B8E8D790Q35881266-40ED210F-EE1C-4BCA-A323-B94708FC9354Q35946480-FC39B439-0644-43BE-A4D8-E71DE8F1EA7EQ36049207-996E03AB-2298-4EDB-B5AA-F52BCC8383FBQ36087928-67893987-ACD6-4E93-875B-CEE8E2782866Q36099612-DE04D0D3-0EAA-4682-8479-F84D9A2C24C3Q36105642-F5CECD6D-73B2-4B14-810E-C53F715991FCQ36141458-7E285E02-F266-40A0-8074-03475D70BC6EQ36152839-EC6024AE-7EF4-4AD2-A1DC-9DDC44CCE63EQ36199995-A9FE7609-8939-44DB-9080-983FF3E83D57Q36286264-8207263F-07E2-4178-B975-E1B4E8E2AB0EQ36320464-0B393F47-36A0-470F-91CA-890291B7C0BBQ36333911-9EC2956F-FC3E-4CD8-8687-17E7E54DEF8EQ36381003-77BA2BA9-8C7A-4BFB-8627-F8CEEE1C314BQ36434450-32040E4F-A80E-4DDF-8F55-B21057EEFD8C
P2860
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The metabolic syndrome or the ...... concepts, and different goals.
@ast
The metabolic syndrome or the ...... concepts, and different goals.
@en
type
label
The metabolic syndrome or the ...... concepts, and different goals.
@ast
The metabolic syndrome or the ...... concepts, and different goals.
@en
prefLabel
The metabolic syndrome or the ...... concepts, and different goals.
@ast
The metabolic syndrome or the ...... concepts, and different goals.
@en
P1476
The metabolic syndrome or the ...... concepts, and different goals.
@en
P304
P356
10.1016/J.ECL.2004.03.002
P577
2004-06-01T00:00:00Z